However, the recently reported putative tumour suppressor in ovarian cancer, opioid-binding protein (OPCML), did not appear to have significant loss of expression in any of the samples studied here (Sellar et al, 2003) (Figure 2E). This evidence concerns the gene OPCML and ovarian carcinoma.